Sign up for the QMED & MD+DI Daily newsletter.
September 14, 2023
2 Min Read
Yellow Dog Productions / The Image Bank via Getty Images
Mayo Clinic and GE Healthcare today announced a strategic collaboration for research and product development programs to better the experience of patients and medical professionals in radiology and the delivery of novel therapies. The companies said they seek to “better equip clinicians with technology to precisely diagnose and treat medical conditions and personalize the patient experience at each step of their care journey through the clinical translation of novel technologies and approaches to medical imaging and theranostics.” The collaboration will be comprised of Mayo Clinic and GE scientists, technology developers, clinicians, and other healthcare professionals.
The Strategic Collaboration for Innovation in Medical Imaging and Theranostics will focus on four core areas, including the rapid acceleration of the development and clinical translation of advanced Magnetic Resonance technologies and techniques through AI enabled exams, and the integration of precise imaging and dosimetry of highly targeted theranostic agents, enabling broader access and more efficient radioisotope production. Additionally, the collaboration intends to make diagnostic and interventional ultrasound easier and faster to use and read while also advancing automation and quantification to improve consistency or care, clinician experience, and patient access. Lastly, they want to leverage multi-modal data, AI, and digital health platforms to streamline clinical operations and support more personalized diagnosis and therapy.
“We are at a critical time in healthcare — technology is rapidly evolving, and we have a responsibility to drive healthcare capabilities through clinical translation and adoption of advanced technologies,” said Matthew Callstrom, MD, PhD, chair of radiology at Mayo Clinic, in a press release announcing the collaboration. “This collaboration brings our research and clinical teams’ expertise and feedback closer to product development and commercialization of innovation, ultimately accelerating the rate of translation of our research to patient care and offering greater opportunity for global impact.”
About the Author(s)
Managing Editor, MD+DI
Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].
You May Also Like
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read
FDA Urges Independent Verification of Third-Party Testing DataFeb 21, 2024|2 Min Read